Catalyst Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US14888U1016

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership581,093 shares
Latest Disclosed Value $ 14,387,863
Citadel Advisors Llc ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 581,093 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $14,387,863 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 308,471 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 88.38% during the quarter. The current value of the position is $18,170,778 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (CPRX) in the form of stock options. The firm currently holds call options representing 12,300 of underlying shares valued at $304,548 USD and put options representing 38,000 of underlying shares valued at $940,880 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CPRX / Catalyst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 581,093 272,622 88.38 14,388 99.85 0.0020
2026-02-17 2025-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 308,471 -89,425 -22.47 7,200 -8.15 0.0010
2025-11-14 2025-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 397,896 137,904 53.04 7,839 38.95 0.0012
2025-08-14 2025-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 259,992 -425,424 -62.07 5,642 -66.06 0.0010
2025-05-15 2025-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 685,416 248,949 57.04 16,621 82.47 0.0032
2025-02-14 2024-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 436,467 411,229 1,629.40 9,109 1,718.16 0.0016
2024-11-14 2024-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 25,238 -557,683 -95.67 502 -94.45 0.0001
2024-08-14 2024-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 582,921 -535,519 -47.88 9,029 -49.35 0.0018
2024-05-15 2024-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 1,118,440 608,336 119.26 17,828 107.92 0.0034
2024-02-14 2023-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 510,104 29,281 6.09 8,575 52.56 0.0017
2023-11-14 2023-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 480,823 315,729 191.24 5,621 153.38 0.0012
2023-08-14 2023-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 165,094 -264,519 -61.57 2,219 -68.86 0.0005
2023-05-15 2023-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 429,613 383,866 839.11 7,123 737.88 0.0016
2023-02-14 2022-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 45,747 45,747 851 0.0002
2022-11-14 2022-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 0 -193,949 -100.00 0 -100.00
2022-08-15 2022-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 193,949 -19,463 -9.12 1,360 -23.12 0.0003
2022-05-16 2022-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 213,412 25,229 13.41 1,769 38.85 0.0004
2022-02-14 2021-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 188,183 -72,376 -27.78 1,274 -7.75 0.0003
2021-11-15 2021-09-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 260,559 53,516 25.85 1,381 16.05 0.0003
2021-08-16 2021-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 207,043 163,506 375.56 1,190 492.04 0.0003
2021-05-21 2021-03-31 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 43,537 -139,000 -76.15 201 -67.05 0.0000
2021-05-17 2021-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 43,537 -139,000 201 0.0000
2021-02-16 2020-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 182,537 -27,652 -13.16 610 -2.40 0.0002
2020-11-16 2020-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 210,189 210,189 625 0.0002
2020-08-14 2020-06-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 0 -874,712 -100.00 0 -100.00
2020-05-15 2020-03-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 874,712 -317,449 -26.63 3,367 -24.68 0.0015
2020-02-14 2019-12-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 1,192,161 1,129,323 1,797.20 4,470 1,238.32 0.0019
2019-11-14 2019-09-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 62,838 -41,340 -39.68 334 -16.50 0.0002
2019-08-14 2019-06-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 104,178 88,859 580.06 400 412.82 0.0002
2019-05-15 2019-03-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 15,319 -55,875 -78.48 78 -43.07 0.0000
2019-02-14 2018-12-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 71,194 53,926 312.29 137 110.77 0.0001
2018-11-13 2018-09-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 17,268 3,217 22.90 65 47.73 0.0000
2018-08-14 2018-06-30 13F/A-1 CATALYST PHARMACEUTICALS Cmn 14888U101 14,051 -87,402 -86.15 44 -81.82 0.0000
2018-08-10 2018-06-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 14,051 -87,402 44
2018-05-14 2018-03-31 13F/A-1 CATALYST PHARMACEUTICALS Cmn 14888U101 101,453 -52,381 -34.05 242 -59.80 0.0001
2018-05-11 2018-03-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 101,453 -52,381 242
2018-02-09 2017-12-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 153,834 143,697 1,417.55 602 2,215.38 0.0004
2017-11-09 2017-09-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 10,137 -650 -6.03 26 -13.33 0.0000
2017-08-11 2017-06-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 10,787 10,787 30 0.0000
2016-08-12 2016-06-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 0 -63,270 -100.00 0 -100.00
2017-01-31 2016-03-31 13F/A-1 CATALYST PHARMACEUTICALS Cmn 14888U101 63,270 -115,364 -64.58 74 -83.07 0.0001
2016-05-13 2016-03-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 63,270 74
2017-01-31 2015-12-31 13F/A-1 CATALYST PHARMACEUTICALS Cmn 14888U101 178,634 36,411 25.60 437 2.58 0.0005
2016-02-12 2015-12-31 13F CATALYST PHARMACEUTICALS Cmn 14888U101 178,634 437
2015-11-16 2015-09-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 142,223 62,462 78.31 426 29.48 0.0004
2015-08-14 2015-06-30 13F CATALYST PHARMACEUTICALS Cmn 14888U101 79,761 44,463 125.96 329 115.03 0.0003
2015-05-15 2015-03-31 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 35,298 -2,999 -7.83 153 35.40 0.0002
2015-02-17 2014-12-31 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 38,297 -44,622 -53.81 113 -58.91 0.0001
2014-11-14 2014-09-30 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 82,919 61,341 284.28 275 400.00 0.0003
2014-08-14 2014-06-30 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 21,578 13,979 183.96 55 223.53 0.0001
2014-05-15 2014-03-31 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 7,599 -11,871 -60.97 17 -55.26 0.0000
2014-02-14 2013-12-31 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 19,470 2,609 15.47 38 153.33 0.0000
2013-08-14 2013-06-30 13F CATALYST PHARMACEUTICAL PART Cmn 14888U101 16,861 16,861 15 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CATALYST PHARMACEUTICALS COM Call 12,300 -75.25 305 -73.77 n/a n/a n/a
2026-02-17 2025-12-31 13F CATALYST PHARMACEUTICALS COM Call 49,700 177.65 1,160 229.26 n/a n/a n/a
2025-11-14 2025-09-30 13F CATALYST PHARMACEUTICALS COM Call 17,900 353 n/a n/a n/a
2025-08-14 2025-06-30 13F CATALYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F CATALYST PHARMACEUTICALS COM Call 21,200 58.21 514 84.23 n/a n/a n/a
2025-02-14 2024-12-31 13F CATALYST PHARMACEUTICALS COM Call 13,400 74.03 280 82.35 n/a n/a n/a
2024-11-14 2024-09-30 13F CATALYST PHARMACEUTICALS COM Call 7,700 -8.33 153 17.69 n/a n/a n/a
2024-08-14 2024-06-30 13F CATALYST PHARMACEUTICALS COM Call 8,400 -26.32 130 -28.18 n/a n/a n/a
2024-05-15 2024-03-31 13F CATALYST PHARMACEUTICALS COM Call 11,400 -68.25 182 -69.98 n/a n/a n/a
2024-02-14 2023-12-31 13F CATALYST PHARMACEUTICALS COM Call 35,900 158.27 603 272.22 n/a n/a n/a
2023-11-14 2023-09-30 13F CATALYST PHARMACEUTICALS COM Call 13,900 -71.28 162 -75.08 n/a n/a n/a
2023-08-14 2023-06-30 13F CATALYST PHARMACEUTICALS COM Call 48,400 -25.99 650 -40.04 n/a n/a n/a
2023-05-15 2023-03-31 13F CATALYST PHARMACEUTICALS COM Call 65,400 157.48 1,084 129.66 n/a n/a n/a
2023-02-14 2022-12-31 13F CATALYST PHARMACEUTICALS COM Call 25,400 -38.35 472 -10.78 n/a n/a n/a
2022-11-14 2022-09-30 13F CATALYST PHARMACEUTICALS COM Call 41,200 138.15 529 337.19 n/a n/a n/a
2022-08-15 2022-06-30 13F CATALYST PHARMACEUTICALS COM Call 17,300 121 n/a n/a n/a
2022-05-16 2022-03-31 13F CATALYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F CATALYST PHARMACEUTICALS COM Call 22,200 111.43 150 167.86 n/a n/a n/a
2021-11-15 2021-09-30 13F CATALYST PHARMACEUTICALS Cmn Call 10,500 56 n/a n/a n/a
2021-08-16 2021-06-30 13F CATALYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CATALYST PHARMACEUTICALS COM Call 39,900 95.59 184 170.59 n/a n/a n/a
2021-05-17 2021-03-31 13F CATALYST PHARMACEUTICALS COM Call 39,900 184 n/a n/a n/a
2021-02-16 2020-12-31 13F CATALYST PHARMACEUTICALS COM Call 20,400 -8.93 68 1.49 n/a n/a n/a
2020-11-16 2020-09-30 13F CATALYST PHARMACEUTICALS COM Call 22,400 13.71 67 -26.37 n/a n/a n/a
2020-08-14 2020-06-30 13F CATALYST PHARMACEUTICALS Cmn Call 19,700 -24.23 91 -9.00 n/a n/a n/a
2020-05-15 2020-03-31 13F CATALYST PHARMACEUTICALS Cmn Call 26,000 100 n/a n/a n/a
2020-02-14 2019-12-31 13F CATALYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F CATALYST PHARMACEUTICALS Cmn Call 18,000 96 n/a n/a n/a
2019-08-14 2019-06-30 13F CATALYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F CATALYST PHARMACEUTICALS Cmn Call 10,900 56 n/a n/a n/a
2019-02-14 2018-12-31 13F CATALYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F CATALYST PHARMACEUTICALS Cmn Call 18,200 69 n/a n/a n/a
2018-02-09 2017-12-31 13F CATALYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-09 2017-09-30 13F CATALYST PHARMACEUTICALS Cmn Call 10,500 -16.00 26 -25.71 n/a n/a n/a
2017-08-11 2017-06-30 13F CATALYST PHARMACEUTICALS Cmn Call 12,500 35 n/a n/a n/a
2016-05-13 2016-03-31 13F CATALYST PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A CATALYST PHARMACEUTICALS Cmn Call 1,300 -63.89 3 -72.73 n/a n/a n/a
2016-02-12 2015-12-31 13F CATALYST PHARMACEUTICALS Cmn Call 1,300 3 n/a n/a n/a
2015-11-16 2015-09-30 13F CATALYST PHARMACEUTICALS Cmn Call 3,600 200.00 11 120.00 n/a n/a n/a
2015-08-14 2015-06-30 13F CATALYST PHARMACEUTICALS Cmn Call 1,200 -36.84 5 -37.50 n/a n/a n/a
2015-05-15 2015-03-31 13F CATALYST PHARMACEUTICAL PART Cmn Call 1,900 72.73 8 166.67 n/a n/a n/a
2015-02-17 2014-12-31 13F CATALYST PHARMACEUTICAL PART Cmn Call 1,100 -87.64 3 -90.00 n/a n/a n/a
2014-11-14 2014-09-30 13F CATALYST PHARMACEUTICAL PART Cmn Call 8,900 178.12 30 275.00 n/a n/a n/a
2014-08-14 2014-06-30 13F CATALYST PHARMACEUTICAL PART Cmn Call 3,200 33.33 8 60.00 n/a n/a n/a
2014-05-15 2014-03-31 13F CATALYST PHARMACEUTICAL PART Cmn Call 2,400 140.00 5 150.00 n/a n/a n/a
2014-02-14 2013-12-31 13F CATALYST PHARMACEUTICAL PART Cmn Call 1,000 2 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CATALYST PHARMACEUTICALS COM Put 38,000 227.59 941 248.15 n/a n/a n/a
2026-02-17 2025-12-31 13F CATALYST PHARMACEUTICALS COM Put 11,600 -33.71 271 -21.51 n/a n/a n/a
2025-11-14 2025-09-30 13F CATALYST PHARMACEUTICALS COM Put 17,500 -21.88 345 -29.22 n/a n/a n/a
2025-08-14 2025-06-30 13F CATALYST PHARMACEUTICALS COM Put 22,400 138.30 486 114.10 n/a n/a n/a
2025-05-15 2025-03-31 13F CATALYST PHARMACEUTICALS COM Put 9,400 -19.66 228 -6.97 n/a n/a n/a
2025-02-14 2024-12-31 13F CATALYST PHARMACEUTICALS COM Put 11,700 -24.03 244 -20.26 n/a n/a n/a
2024-11-14 2024-09-30 13F CATALYST PHARMACEUTICALS COM Put 15,400 133.33 306 200.00 n/a n/a n/a
2024-08-14 2024-06-30 13F CATALYST PHARMACEUTICALS COM Put 6,600 -90.18 102 -90.48 n/a n/a n/a
2024-05-15 2024-03-31 13F CATALYST PHARMACEUTICALS COM Put 67,200 220.00 1,071 203.40 n/a n/a n/a
2024-02-14 2023-12-31 13F CATALYST PHARMACEUTICALS COM Put 21,000 -47.76 353 -24.73 n/a n/a n/a
2023-11-14 2023-09-30 13F CATALYST PHARMACEUTICALS COM Put 40,200 23.69 470 7.57 n/a n/a n/a
2023-08-14 2023-06-30 13F CATALYST PHARMACEUTICALS COM Put 32,500 23.11 437 -0.23 n/a n/a n/a
2023-05-15 2023-03-31 13F CATALYST PHARMACEUTICALS COM Put 26,400 -48.44 438 -54.10 n/a n/a n/a
2023-02-14 2022-12-31 13F CATALYST PHARMACEUTICALS COM Put 51,200 53.75 952 122.95 n/a n/a n/a
2022-11-14 2022-09-30 13F CATALYST PHARMACEUTICALS COM Put 33,300 74.35 427 218.66 n/a n/a n/a
2022-08-15 2022-06-30 13F CATALYST PHARMACEUTICALS COM Put 19,100 -4.02 134 -18.79 n/a n/a n/a
2022-05-16 2022-03-31 13F CATALYST PHARMACEUTICALS COM Put 19,900 165 n/a n/a n/a
2022-02-14 2021-12-31 13F CATALYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F CATALYST PHARMACEUTICALS Cmn Put 32,600 -70.60 173 -72.88 n/a n/a n/a
2021-08-16 2021-06-30 13F CATALYST PHARMACEUTICALS COM Put 110,900 268.44 638 358.99 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CATALYST PHARMACEUTICALS COM Put 30,100 -39.80 139 -16.77 n/a n/a n/a
2021-05-17 2021-03-31 13F CATALYST PHARMACEUTICALS COM Put 30,100 139 n/a n/a n/a
2021-02-16 2020-12-31 13F CATALYST PHARMACEUTICALS COM Put 50,000 309.84 167 363.89 n/a n/a n/a
2020-11-16 2020-09-30 13F CATALYST PHARMACEUTICALS COM Put 12,200 3.39 36 -34.55 n/a n/a n/a
2020-08-14 2020-06-30 13F CATALYST PHARMACEUTICALS Cmn Put 11,800 -49.57 55 -38.89 n/a n/a n/a
2020-05-15 2020-03-31 13F CATALYST PHARMACEUTICALS Cmn Put 23,400 -41.65 90 -40.00 n/a n/a n/a
2020-02-14 2019-12-31 13F CATALYST PHARMACEUTICALS Cmn Put 40,100 -6.96 150 -34.50 n/a n/a n/a
2019-11-14 2019-09-30 13F CATALYST PHARMACEUTICALS Cmn Put 43,100 50.17 229 108.18 n/a n/a n/a
2019-08-14 2019-06-30 13F CATALYST PHARMACEUTICALS Cmn Put 28,700 115.79 110 61.76 n/a n/a n/a
2019-05-15 2019-03-31 13F CATALYST PHARMACEUTICALS Cmn Put 13,300 68 n/a n/a n/a
2019-02-14 2018-12-31 13F CATALYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F CATALYST PHARMACEUTICALS Cmn Put 24,000 91 n/a n/a n/a
2018-02-09 2017-12-31 13F CATALYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-09 2017-09-30 13F CATALYST PHARMACEUTICALS Cmn Put 13,500 34 n/a n/a n/a
2016-05-13 2016-03-31 13F CATALYST PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A CATALYST PHARMACEUTICALS Cmn Put 5,300 96.30 13 62.50 n/a n/a n/a
2016-02-12 2015-12-31 13F CATALYST PHARMACEUTICALS Cmn Put 5,300 13 n/a n/a n/a
2015-11-16 2015-09-30 13F CATALYST PHARMACEUTICALS Cmn Put 2,700 -10.00 8 -33.33 n/a n/a n/a
2015-08-14 2015-06-30 13F CATALYST PHARMACEUTICALS Cmn Put 3,000 -28.57 12 -33.33 n/a n/a n/a
2015-05-15 2015-03-31 13F CATALYST PHARMACEUTICAL PART Cmn Put 4,200 281.82 18 500.00 n/a n/a n/a
2015-02-17 2014-12-31 13F CATALYST PHARMACEUTICAL PART Cmn Put 1,100 -96.27 3 -96.94 n/a n/a n/a
2014-11-14 2014-09-30 13F CATALYST PHARMACEUTICAL PART Cmn Put 29,500 2,007.14 98 2,350.00 n/a n/a n/a
2014-08-14 2014-06-30 13F CATALYST PHARMACEUTICAL PART Cmn Put 1,400 366.67 4 300.00 n/a n/a n/a
2014-02-14 2013-12-31 13F CATALYST PHARMACEUTICAL PART Cmn Put 300 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.